Monday, December 23, 2024

Breakthrough Discoveries in Human Immunology – Michelson Philanthropies and AAAS/Science Award Transformative Research

Michelson Philanthropies and AAAS/Science award Dr. Aleksandar Obradovic,of the Department of Systems Biology at Columbia University Irving Medical Center, with the 2023 Michelson Philanthropies & Science Prize for Immunology. He is awarded the $30,000 grand prize for his winning essay “Precision Immunotherapy – A Mechanistic Approach to Overcoming Treatment Resistance.” His research focuses on the development of novel tools to understand the complex immune makeup of cancers and their escape mechanisms in response to treatment. Dr. Obradovic’s approach delivers a tailored combination of drugs to treatment-resistant cancer patients with the potential to critically improve immunotherapy efficacy.

“The Science editors and judges were exceedingly impressed with Dr. Obradovic’s cutting-edge work, which has important implications well beyond its original focus on cancer immunotherapy,” says Seth Thomas Scanlon, Senior Editor at Science. “Moreover, we found his essay tremendously compelling, as he highlighted his accomplishments in an exciting and very accessible way.”

Also read: Surfacide Announces Expansion Of UV-C Disinfection Technology Across All MedStar Health Hospital Locations

Dr. Roser Vento-Tormo of the Wellcome Sanger Institute, andDr. Joshua Tanof the National Institutes of Health receive the $10,000 finalist awards.

“No field of medical research has more potential to transform the trajectory of human health care than does immunology,” says Dr. Gary K. Michelson, founder and co-chair of Michelson Philanthropies and the Michelson Medical Research Foundation. “We established the Michelson Philanthropies & Science Prize for Immunology in partnership with the American Association for the Advancement of Science to support brilliant and imaginative early-career researchers, so they can revolutionize the field of immunology.”

The recipients were selected by a distinguished committee of international scientists chaired by Science editors who judged the editorial essays based on research conducted over the last three years, and long-term impact on vaccine and immunotherapeutic discovery.

SOURCE: Businesswire

Subscribe Now

    Hot Topics